drugset / Trial / NCT00147576

Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects.

NCT00147576 ↗

Phase 2 Completed 88 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

Test the hypothesis that increasing doses of CP-866,087 will decrease the total number of drinks consumed during a 2 hour acute alcohol consumption assessment and to determine the safety and tolerability of multiple doses of CP-866,087 in alcohol dependent subjects compared to placebo.

Timeline

Start
2003-12
Primary completion
—
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject CP-866,087 Small molecule — —

Indications